186 related articles for article (PubMed ID: 33179097)
1. Effects of signaling pathway inhibitors on hematopoietic stem cells.
Jiang Y; Xu Z; Ma N; Yin L; Hao C; Li J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179097
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p38 mitogen-activated protein kinase promotes ex vivo hematopoietic stem cell expansion.
Wang Y; Kellner J; Liu L; Zhou D
Stem Cells Dev; 2011 Jul; 20(7):1143-52. PubMed ID: 21198398
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle.
Dionyssiou MG; Nowacki NB; Hashemi S; Zhao J; Kerr A; Tsushima RG; McDermott JC
J Mol Cell Cardiol; 2013 Jan; 54():35-44. PubMed ID: 23137781
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of p38 MAPK activity promotes ex vivo expansion of human cord blood hematopoietic stem cells.
Zou J; Zou P; Wang J; Li L; Wang Y; Zhou D; Liu L
Ann Hematol; 2012 Jun; 91(6):813-23. PubMed ID: 22258328
[TBL] [Abstract][Full Text] [Related]
5. Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice.
Huang J; Zhang Y; Bersenev A; O'Brien WT; Tong W; Emerson SG; Klein PS
J Clin Invest; 2009 Dec; 119(12):3519-29. PubMed ID: 19959876
[TBL] [Abstract][Full Text] [Related]
6. Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells.
Reddiconto G; Toto C; Palamà I; De Leo S; de Luca E; De Matteis S; Dini L; Passerini CG; Di Renzo N; Maffia M; Coluccia AM
Blood; 2012 Mar; 119(10):2335-45. PubMed ID: 22262776
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth.
Holmes T; O'Brien TA; Knight R; Lindeman R; Shen S; Song E; Symonds G; Dolnikov A
Stem Cells; 2008 May; 26(5):1288-97. PubMed ID: 18323411
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells.
Bug G; Gül H; Schwarz K; Pfeifer H; Kampfmann M; Zheng X; Beissert T; Boehrer S; Hoelzer D; Ottmann OG; Ruthardt M
Cancer Res; 2005 Apr; 65(7):2537-41. PubMed ID: 15805245
[TBL] [Abstract][Full Text] [Related]
9. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
11. GSK3β, but not GSK3α, inhibits the neuronal differentiation of neural progenitor cells as a downstream target of mammalian target of rapamycin complex1.
Ahn J; Jang J; Choi J; Lee J; Oh SH; Lee J; Yoon K; Kim S
Stem Cells Dev; 2014 May; 23(10):1121-33. PubMed ID: 24397546
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Expansion of Hematopoietic Stem Cells by Inhibition of Both GSK3 and p38 Signaling.
Li J; Zhang L; Yin L; Ma N; Wang T; Wu Y; Wang M; Yang X; Xu H; Hao C; Li W; Wei W; Xu Y; Zhang F; Breslin P; Zhang J; Zhang J
Stem Cells Dev; 2019 Nov; 28(22):1486-1497. PubMed ID: 31552804
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells.
Ito K; Hirao A; Arai F; Takubo K; Matsuoka S; Miyamoto K; Ohmura M; Naka K; Hosokawa K; Ikeda Y; Suda T
Nat Med; 2006 Apr; 12(4):446-51. PubMed ID: 16565722
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Glycogen Synthase Kinase 3β Increases the Proportion and Suppressive Function of CD19
Li J; Gao J; Zhou H; Zhou J; Deng Z; Lu Y; Rao J; Ji G; Gu J; Yang X; Xia Y; Wang X
Front Immunol; 2020; 11():603288. PubMed ID: 33343576
[TBL] [Abstract][Full Text] [Related]
15. mTOR Signaling as a Regulator of Hematopoietic Stem Cell Fate.
Fernandes H; Moura J; Carvalho E
Stem Cell Rev Rep; 2021 Aug; 17(4):1312-1322. PubMed ID: 33586059
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of GSK-3β activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK/mTOR signaling.
Fang G; Zhang P; Liu J; Zhang X; Zhu X; Li R; Wang H
Cancer Lett; 2019 Oct; 463():11-26. PubMed ID: 31404613
[TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine phosphatase SHP-1 modulates osteoblast differentiation through direct association with and dephosphorylation of GSK3β.
Tang XL; Wang CN; Zhu XY; Ni X
Mol Cell Endocrinol; 2017 Jan; 439():203-212. PubMed ID: 27614023
[TBL] [Abstract][Full Text] [Related]
18. Brief Report: A Differential Transcriptomic Profile of Ex Vivo Expanded Adult Human Hematopoietic Stem Cells Empowers Them for Engraftment Better than Their Surface Phenotype.
Psatha N; Georgolopoulos G; Phelps S; Papayannopoulou T
Stem Cells Transl Med; 2017 Oct; 6(10):1852-1858. PubMed ID: 28801972
[TBL] [Abstract][Full Text] [Related]
19. SB203580, a p38MAPK inhibitor, attenuates olfactory dysfunction by inhibiting OSN apoptosis in AR mice (activation and involvement of the p38 mitogen-activated protein kinase in olfactory sensory neuronal apoptosis of OVA-induced allergic rhinitis).
Gao X; Li N; Zhang J
Brain Behav; 2019 Jun; 9(6):e01295. PubMed ID: 31041850
[TBL] [Abstract][Full Text] [Related]
20. SB203580 reverses memory deficits and depression-like behavior induced by microinjection of Aβ
Guo J; Chang L; Li C; Li M; Yan P; Guo Z; Wang C; Zha Q; Wang Q
Metab Brain Dis; 2017 Feb; 32(1):57-68. PubMed ID: 27488110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
